Metropolis Healthcare Limited (NSE:METROPOLIS)

Market Cap	78.19B
Revenue (ttm)	13.17B
Net Income (ttm)	1.52B
Shares Out	51.27M
EPS (ttm)	29.57
PE Ratio	51.58
Forward PE	38.56
Dividend	4.00 (0.26%)
Ex-Dividend Date	n/a

Volume	88,061
Average Volume	103,523
Open	1,574.00
Previous Close	1,564.55
Day's Range	1,515.50 - 1,574.00
52-Week Range	1,515.50 - 2,318.30
Beta	0.41
RSI	32.74
Earnings Date	May 21, 2025

About Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India and internationally. The company offers clinical laboratory testing, and profiles services. It also provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, and confirmation and/or monitoring of the disease. In addition, the company offers corporate wellness, laborat...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1981
• Employees: 4,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: METROPOLIS

Financial Performance

In 2023, Metropolis Healthcare's revenue was 12.08 billion, an increase of 5.18% compared to the previous year's 11.48 billion. Earnings were 1.28 billion, a decrease of -10.54%.